1. Reverse vaccinology as an approach for developing Histophilus somni vaccine candidates.
- Author
-
Madampage CA, Rawlyk N, Crockford G, Wang Y, White AP, Brownlie R, Van Donkersgoed J, Dorin C, and Potter A
- Subjects
- Animals, Antigens, Bacterial genetics, Antigens, Bacterial immunology, Bacterial Proteins genetics, Bacterial Proteins immunology, Blotting, Western, Cattle, Cattle Diseases microbiology, Computer Simulation, DNA, Bacterial isolation & purification, Gene Library, Haemophilus Infections microbiology, Haemophilus Infections prevention & control, Haemophilus somnus genetics, Haemophilus somnus isolation & purification, Haemophilus somnus pathogenicity, Models, Genetic, Open Reading Frames genetics, Recombinant Fusion Proteins immunology, Recombinant Fusion Proteins isolation & purification, Sequence Analysis, DNA, Virulence, Bacterial Vaccines immunology, Cattle Diseases prevention & control, Computational Biology methods, DNA, Bacterial genetics, Genome, Bacterial, Haemophilus Infections veterinary, Haemophilus somnus immunology
- Abstract
Histophilosis of cattle is caused by the Gram negative bacterial pathogen Histophilus somni (H. somni) which is also associated with the bovine respiratory disease (BRD) complex. Existing vaccines for H. somni include either killed cells or bacteria-free outer membrane proteins from the organism which have proven to be moderately successful. In this study, reverse vaccinology was used to predict potential H. somni vaccine candidates from genome sequences. In turn, these may protect animals against new strains circulating in the field. Whole genome sequencing of six recent clinical H. somni isolates was performed using an Illumina MiSeq and compared to six genomes from the 1980's. De novo assembly of crude whole genomes was completed using Geneious 6.1.7. Protein coding regions was predicted using Glimmer3. Scores from multiple web-based programs were utilized to evaluate the antigenicity of these predicted proteins which were finally ranked based on their surface exposure scores. A single new strain was selected for future vaccine development based on conservation of the protein candidates among all 12 isolates. A positive signal with convalescent serum for these antigens in western blots indicates in vivo recognition. In order to test the protective capacity of these antigens bovine animal trials are ongoing., (Copyright © 2015 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF